Evaluation of HNF1B , KLK3 , ELAC2 , TMPRSS2‐ERG , and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE‐UERJ
The Prostate · 2024
DOI: 10.1002/pros.24635 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Raphaela Dos Santos Menezes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Human and Experimental Biology Graduate Program, IBRAG, Rio de Janeiro State University, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: FAPERJ (Fundação do Amparo à Pesquisa do Estado do Rio de Janeiro), CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico do Brasil).
Abstract (Originalsprache)
Purpose
Prostate cancer (PCa) is the leading cause of death among men in 48 countries. Genetic alterations play a significant role in PCa carcinogenesis. For the hypothesis of this research, five unique polymorphisms (SNP) were investigated in different genes that showed to be associated in different ways with PCa: rs4430796, rs2735839, rs4792311, rs12329760, and rs28931588, respectively for the genes HNF1B , KLK3 , ELAC2 , TMPRSS2‐ERG , and CTNNB1 . Patients and Methods Blood samples from 426 subjects were evaluated: 290 controls (161 females and 129 males) and 136 PCa patients. SNP were determined by real‐time polymerase chain reaction. TaqMan SNP genotyping assay. In the control samples, the SNPs were defined in association with the self‐reported ethnicity, and in 218 control samples with markers with ancestry indicators. The genes were in Hardy–Weinberg equilibrium. One hundred and seventy control samples were matched by ethnicity for comparison with the PCa samples.
Results
The G allele at rs28931588 was monomorphic in both patients and controls studied. Significant differences were observed in allelic and genotypic frequencies between the control and Pca samples in rs2735839 ( KLK3 ; p = 0.002 and χ 2 = 8.73 and p = 0.01, respectively), by the global frequency and in the dominant model rs2735839_GG (odds ratio [OR] = 0.51, p = 0.02). AA and GA genotypes at rs4792311 ( ELAC2 ) were more frequent in patients with Gleason 7(4 + 3), 8, and 9 ( n = 37%–59.7%) compared to patients with Gleason 6 and 7(3 + 4) ( n = 26%–40.0%) conferring a protective effect on the GG genotype (OR = 0.45, p = 0.02). The same genotype showed an OR = 2.71 ( p = 0.01) for patients with low severity. The HNF1B – KLK3 – ELAC2 – TMPRSS2‐ERG haplotypes: GAAT, AAAT, GAGT, and AAGT were more frequent in patients with Pca with OR ranging from 4.65 to 2.48.
Conclusions
Higher frequencies of risk alleles were confirmed in the SNPs, KLK3 rs2735839_A, ELAC2 rs4792311_A, and TMPRSS2 rs12329760_T in patients with Pca. Rs2735839_A was associated with risk of Pca and rs4792311_A with severity and Gleason score of 7(4 + 3) or greater. There is a need for careful observation of rs2735839 and rs4792311 in association with the prostatic biopsy due to the increased risk of Pca.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Human and Experimental Biology Graduate Program, IBRAG, Rio de Janeiro State University, Rio de Janeiro, Brazil.
- Urology Teaching Assistance Unit (UDA), FCM, Pedro Ernesto University Hospital (HUPE) and the Piquet Carneiro University Polyclinic (PPC), Rio de Janeiro State University, Rio de Janeiro, Brazil.
- Anatomopathological Service Pedro Ernesto University Hospital (HUPE), FCM, Rio de Janeiro State University, Rio de Janeiro, Brazil.
- Tissue Repair and Histocompatibility Technological Core (Tixus), Rio de Janeiro State University, Rio de Janeiro, Brazil.
- Laboratory of DNA Diagnostic, IBRAG, Rio de Janeiro State University, Rio de Janeiro, Brazil.
ORCID-Profile: Gabriele Alves de Souza Carvalho, Luís Cristóvão Porto
Förderung
- FAPERJ (Fundação do Amparo à Pesquisa do Estado do Rio de Janeiro)
- CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico do Brasil)
Zitieren
APA
Menezes, R. D. S., Dornas, M. C., Campos, C. F. F., Rodeiro, D. B., Carrerette, F. B., Oliveira, R. V., de Souza, B. A., Alves de Souza Carvalho, G., Brito, I. A. A., Silva, D. A., Damião, R., & Porto, L. C. (2024). Evaluation of HNF1B , KLK3 , ELAC2 , TMPRSS2‐ERG , and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE‐UERJ. The Prostate. https://doi.org/10.1002/pros.24635
Vancouver
Menezes RDS, Dornas MC, Campos CFF, Rodeiro DB, Carrerette FB, Oliveira RV, et al. Evaluation of HNF1B , KLK3 , ELAC2 , TMPRSS2‐ERG , and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE‐UERJ. The Prostate. 2024. doi:10.1002/pros.24635
BibTeX
@article{Menezes2024,
author = {Menezes, Raphaela Dos Santos and Dornas, Maria Cristina and Campos, Carlos Frederico Ferreira and Rodeiro, Daniela Bouzas and Carrerette, Fabricio Borges and Oliveira, Romulo Vianna and de Souza, Brenda Amaral and Alves de Souza Carvalho, Gabriele and Brito, Ingrid Alexandre de Abreu and Silva, Dayse Aparecida and Damião, Ronaldo and Porto, Luís Cristóvão},
title = {Evaluation of HNF1B , KLK3 , ELAC2 , TMPRSS2‐ERG , and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE‐UERJ},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24635}
}
EUVIMED